Drug Model Hierarchy
description
Transcript of Drug Model Hierarchy
![Page 1: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/1.jpg)
Evaluation of the Proposed Clinical Drug Term Model
James CiminoHL7 Vocabulary Technical Committee
April 26, 1999Toronto, Ontario
![Page 2: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/2.jpg)
Drug Model Hierarchy
Drug Class
Not-Fully-Specified Drug
Clinical Drug
Trademark Drug
Manufactured Components
Ingredient Class
International Package Identifiers
Country-Specific Packaged Product
Ingredient
is-a
is-a
is-a
is-a
is-a
is-a
Chemicals
MedicationsPackages
Composite Clinical Drug
is-a
Composite Trademark Drug
is-a
![Page 3: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/3.jpg)
Drug Model Hierarchy
Drug Class
Not-Fully-Specified Drug
Trademark Drug
Manufactured Components
Ingredient Class
International Package Identifiers
Country-Specific Packaged Product
Ingredient
is-a
is-a
is-a
is-a
is-a
is-a
Chemicals
MedicationsPackages
Composite Clinical Drug
is-a
Composite Trademark Drug
is-a
Clinical Drug
![Page 4: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/4.jpg)
Clinical Drugs
• Dosage form
• Active ingredients– Chemical
– Form Strength• Strength amount
• Strength units
• Volume
• Volume units
![Page 5: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/5.jpg)
Experiment
• Can model allow for interoperability?– Single terminology vs.– Mapping between terminologies
• Select random sample of drug terms
• Obtain descriptions from terminology developers
• Compare description components
• Examine overall match rate
![Page 6: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/6.jpg)
Sample Selection
• 71,000 NDC Codes
• 1000 selected at random (1.4%)
• Many are obsolete
![Page 7: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/7.jpg)
Descriptions from Vendors
Name Form Ingredient 1 Ingredient 2
Valium 5mg Tablet Tablet Diazepam ^5^mg
Tylenol #3 Tablet Acetaminophen Codeine ^325^mg ^30^mg
Chloral Hydrate Syrup Syrup Chloral Hydrate 100.000000^mg^1.000000^ml
![Page 8: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/8.jpg)
Descriptions from Vendors
Set Mapped
A 358
B 459
C 605
D 405
E 566
A B C D E None
- 340 358 326 357 642
340 - 452 361 449 541
358 452 - 393 554 395
326 361 393 - 392 395
357 449 554 392 - 434
Overall, 367 terms were not represented in any set, 71 appeared in only one set, 77 appeared in exactly two sets, 83 appeared in three sets, 91 appeared in four, and 311 terms appeared in all five terminologies.
![Page 9: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/9.jpg)
Pairwise Comparisons
Set B C D E
A 340 358 326 357
B 452 361 449
C 393 554
D 392
E
![Page 10: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/10.jpg)
Pairwise Comparisons
Set B C D E
A 340 358 326 357
B 452 361 449
C 393 554
D 392
E
{3982
![Page 11: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/11.jpg)
Comparisons
• Dosage Form: 3982
• Ingredient (number and match): 5507
• Dose Strength (dose, units, volume, volume units): 4337
• Overall: 3982
![Page 12: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/12.jpg)
Dosage Form Matching
• TAB = TABLET
• LIQUID ORAL LIQUID
• 111 Dosage form synonyms
![Page 13: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/13.jpg)
Ingredient Matching
• HCl vs. Hydrochloride
• Salt vs. Base
• Inclusion of form or route
• Mention of animal source
![Page 14: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/14.jpg)
Dose Strength Matching
• Standard format (000050000 vs. 500.00)
• Normalization of units (GM vs. MG)
![Page 15: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/15.jpg)
Dose Units Matching
• Standard abbreviations
• Normalization of units (GM vs. MG)
• Missing values
• Inclusion of concentration information
• MG vs. %
![Page 16: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/16.jpg)
Dose Volume Matching
• Not given
• Different numeric formats
• Defaults (0 and 1)
• Different volumes ( per 1ml vs per 5ml)
![Page 17: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/17.jpg)
Dose Volume Units Matching
• Not given
• “Each”
• Different abbreviations
![Page 18: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/18.jpg)
Overall Matching
• Form matches
• Same number of ingredients
• Each ingredient matches on chemical and all four other parameters
![Page 19: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/19.jpg)
Overall Matching
Total Before After Conversion Conversion Components: Ingredients 5507 3607 (65%) 4337 (79%) Strength 4337 374 (9%) 3262 (75%) Units 4337 1845 (43%) 2964 (68%) Volume 4337 1054 (24%) 3754 (87%) Volume Units 4337 2319 (53%) 3486 (80%)
Components:
Overall: Each Ingred 4337 0 (0%) 2773 (64%) All Ingred 3982 0 (0%) 2519 (63%) Dose Form 3982 645 (16%) 2859 (72%) Complete Drug 3982 0 (0%) 2128 (53%)
![Page 20: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/20.jpg)
Pairwise Comparisons
Set A B C D E
A - 340 358 326 357
B 340 - 452 361 449
C 358 452 - 393 554
D 326 361 393 - 392
E 357 449 554 392 -
![Page 21: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/21.jpg)
Set A B C D E
A - 59% 45% 48% 52%
B 59% - 54% 63% 62%
C 45% 54% - 46% 48%
D 48% 63% 46% - 58%
E 52% 62% 48% 58% -
Pairwise Complete Matches
![Page 22: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/22.jpg)
Example of MismatchGUAIFENESIN AC LIQUID|10;100|MG/5ML;MG/|LIQUID
SYRUP|GUAIFENESIN^00000000.000^^0000.000^CODEINE PHOSPHATE^.^^.^
LIQUID|CODEINE PHOSPHATE^2.000000^MG^^GUAIFENESIN^20.000000^MG^1.000000^ML
LIQUID, ORAL (SYSTEMIC)|CODEINE PHOSPHATE^10^MG^5^MLGUAIFENESIN^100^MG^5^ML
LIQUID|CODEINE PHOSPHATE^10.0000^MG/5ML^^GUAIFENESIN^100.0000^MG/5ML^^
SYRUP|CODEINE PHOSPHATE^10^MILLIGRAM(S)^5^MILLILITER(S)GUAIFENESIN^100^MILLIGRAM(S)^5^MILLILITER(S)
![Page 23: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/23.jpg)
Example of Mismatch
BUMEX INJECTION|0.25|MG|INJ-SOL
AMPUL
BUMETANIDE^00000000.250^MG^0001.000^ML
INJECTION
SODIUM CHLORIDE, IV USE^0.850000^%^^
BUMETANIDE, INJECTABLE^0.250000^MG^1.000000^ML
INJECTION
BUMETANIDE^0.25^MG^1^ML
SOLUTION
BUMETANIDE^0.2500^MG/ML^^
SOLUTION
BUMETANIDE^0.25^MILLIGRAM(S)^1^MILLILITER(S)
![Page 24: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/24.jpg)
Example of Mismatch
RECOMBIVAX HB ADULT FORMULATION INJECTION|10|MCG|INJ-SUS
VIAL
HEPATITIS B VIRUS VACCINE^00000010.000^MCG^0001.000^ML
INJECTION
HEPATITIS B SURFACE ANTIGEN^10.000000^MCG^1.000000^ML
INJECTION
HEPATITIS B VACCINE-RECOMBINANT^10^MCG^1^ML
INJECTION
HEPATITIS B VIRUS VACCINE RECOMBINANT^10.0000^MCG/ML ^^
SOLUTION
HEPATITIS B VACCINE RECOMBINANT^10^MICROGRAM(S)^ 1^MILLILITER(S)
![Page 25: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/25.jpg)
Discussion
• Matching is still far from perfect
• Not surprising, given lack of standards for attribute values
• Next steps
![Page 26: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/26.jpg)
Discussion: Next Steps
• Define some rules for each field
• Select new random sample
• Find subset with good overlap across terminologies
• Submit descriptions of new subset
![Page 27: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/27.jpg)
Discussion: New Rules
• Dose forms: separate translation step• Ingredients:
– Right number– Specific chemical entity– Identifiers (UMLS?)– Don’t mix in route or concentration
• Strengths:– Conversion algorithms– Rules for defaults– Don’t mix route or concentration with strength
![Page 28: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/28.jpg)
Conclusions
• Glass half empty:– How can we do automated translation of patient
data?– Can drug order transfers and decision support
be safe?
• Glass half full:– No attempt yet to standardize attribute
terminology– Most translation was much better than 50%– Just getting started– Better than what we do now
![Page 29: Drug Model Hierarchy](https://reader035.fdocuments.net/reader035/viewer/2022070403/568139d6550346895da18a38/html5/thumbnails/29.jpg)